Epidemiology and HIV Transmission in Injection Drug Users

HIV InSite Knowledge Base Chapter
Published May 1998
Jeffrey H. Burack, MD, MPP, BPhil, University of California San Francisco
David Bangsberg, MD, MPH, University of California San Francisco
http://hivinsite.ucsf.edu/InSite?page=kb-07-04-01

Figure 2. Historical reconstruction of HIV type 1 seroprevalence among active IDUs in Manhattan, New York City


Fig. 2. Historical reconstruction of HIV type 1 seroprevalence among active IDUs in Manhattan, New York City. Reconstruction is based on seroprevalence data for 1978 through 1984 and 1986 through 1987, with AIDS case data used to estimate seroprevalence for other years. Curve has been smoothed for 1984 through 1987. (Adapted from Des Jarlais DCm Friedman SR, Novick DM, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1997 through 1987. JAMA 1989;261:1010; and Des Jarlais DC, Friedman SR, Sotheran J, et al. Continuity and change within an epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA 1994;271:121.)